Zai Lab Announces NDA Acceptance of Sulbactam-Durlobactam (SUL-DUR) for Infections Caused by Acinetobacter baumannii in China by the NMPA
Source:
Nasdaq GlobeNewswire
/
22 Feb 2023 06:30:00 America/Chicago
N/A
Share on,